Navigating the landscape of end-of-life care and access to medications like Nembutal in New South Wales, Australia, requires a careful understanding of the complex legal system. Currently, Pentobarbital does not have a approved place on the Pharmaceutical Benefits Scheme (this program) and is therefore not routinely prescribed by medical profession